Pancreatic endocrine tumors (PETs) represent an important subset of pancreatic neoplasms. Patients with completely resected tumors generally have a good prognosis, and an aggressive surgical approach in patients with advanced disease may also prolong survival. The authors of this Review discuss the current surgical management strategies for treating PETs, focusing on insulinomas, gastrinomas and nonfunctional PETs.
- Volker Fendrich
- Jens Waldmann
- Peter Langer